Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)TOL-463 Phase 2 Study for Vaginitis
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Toltec Pharmaceuticals, LLC
- Target Recruit Count
- 106
- Registration Number
- NCT02866227
- Locations
- 🇺🇸
University of Alabama at Birmingham School of Medicine- Infectious Disease, Birmingham, Alabama, United States
🇺🇸University of Washington - Harborview Medical Center - Center for AIDS and STD, Seattle, Washington, United States
News
No news found